Huons Meditech (CEO Chun Cheong-woon) announced on the 5th that it participated in the Urological Association of Asia 2023, 

the largest urological conference in Asia, held in Dubai and the United Arab Emirates from the 28th of last month to the 1st.

The Asian Urological Society, held every year, is a venue for development and exchange in urology where over 3,000 urologists from around the world gather.

At this exhibition, Huons Meditech attracted the attention of overseas buyers and visitors by introducing ‘URO-EMXD’, a premium extracorporeal shock wave lithotripsy device that improved image quality and increased convenience of treatment, 

and IMPO88, which was the first in Korea to prove its efficacy in treating erectile dysfunction.

Through this conference, Huons Meditech introduced the SDS-5000, which it acquired from MITEC last August, as well as the ASADAL M1 and MASON M1, which have completed FDA and CE certification, in addition to the three types of lithotripters of the existing URO series.